Medical AI can detect the racial identity of patients from x-rays. This is extremely concerning, and raises urgent questions about how we test medical AI systems.
The way we currently report human performance systematically underestimates it, making AI look better than it is.
Super-resolution promises to be one of the most impactful medical imaging AI technologies, but only if it is safe.
This week we saw the FDA approve the first MRI super-resolution product, from the same company that received approval for a similar PET product last year. This news seems as good a reason as any to talk about the safety concerns myself and many other people have with these systems.
Medical AI testing is unsafe, but addressing hidden stratification may be a way to prevent harm, without upending the current regulatory environment.
I discuss a piece of medical AI research that has not received much attention, but actually did a proper clinical trial!
My first impressions of these datasets. How do they measure up, and how useful might they be?
Medical AI has a safety problem; we know for a fact our testing isn't reliable. We've seen how this plays out before.
For the first time ever AI systems can directly harm patients. Are we doing enough to prevent a medical AI tragedy, the equivalent of a thalidomide event?